Publications by authors named "Melanie D Whittington"

Claim this Profile
E
Estimating the societal economic burden of food allergy in the United States.
Christopher Warren, Melanie D Whittington, Lucy Bilaver, David Kratochvil, Rongzhe Liu

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses.
Melanie D Whittington, Joshua T Cohen, Peter J Neumann, Tyler D Wagner, Jonathan D Campbell

Value Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges with judging and interpreting a drug's launch price.
Melanie D Whittington, Louis P Garrison, Jonathan D Campbell

Am J Manag Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers.
Sean R Tunis, Jason Shafrin, Kyi-Sin Than, Melanie D Whittington, Richard J Willke

Health Aff Sch· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating a Drug's Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold.
Melanie D Whittington, T Joseph Mattingly

Appl Health Econ Health Policy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and value of ensifentrine for the treatment of chronic obstructive pulmonary disease.
Abigail C Wright, Grace A Lin, Melanie D Whittington, Avery McKenna, Finn Raymond

J Manag Care Spec Pharm· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.
Avery McKenna, Jeffrey A Tice, Melanie D Whittington, Abigail C Wright, Marina Richardson

J Manag Care Spec Pharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices.
Jason Shafrin, Jaehong Kim, Joshua T Cohen, Louis P Garrison, Dana A Goldman, Melanie D Whittington

Forum Health Econ Policy· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
Dmitriy Nikitin, Grace A Lin, Melanie D Whittington, Emily Nhan, Yasmine Kayali

J Manag Care Spec Pharm· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of : an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa.
Melanie D Whittington, Kathy Goggin, Lungiswa Tsolekile, Thandi Puoane, Andrew T Fox

Glob Health Action· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Alternative Measure of Health for Value Assessment: The Equal Value Life-Year.
Jonathan D Campbell, Melanie D Whittington, Steven D Pearson

Pharmacoeconomics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.
Abigail C Wright, Grace A Lin, Melanie D Whittington, Foluso Agboola, Serina Herron-Smith

J Manag Care Spec Pharm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value.
Avery McKenna, Grace A Lin, Melanie D Whittington, Dmitriy Nikitin, Serina Herron-Smith

J Manag Care Spec Pharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in cardiac testing resource utilization using two different risk stratification schemes.
Robin J Tyner, Melanie D Whittington, Vanessa P Patterson, Michael Ho, Sharon Pincus

Am J Emerg Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living Health Technology Assessment: Issues, Challenges and Opportunities.
Praveen Thokala, Tushar Srivastava, Robert Smith, Shijie Ren, Melanie D Whittington

Pharmacoeconomics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of the Rural Transitions Nurse Program for Veterans on Healthcare Utilization Costs.
Piper H Williams, Heather M Gilmartin, Chelsea Leonard, Michaela S McCarthy, Lynette Kelley, Melanie D Whittington

J Gen Intern Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral treatments for outpatient COVID-19: Effectiveness and value.
Molly Beinfeld, Kai Yeung, Melanie D Whittington, Rasheed Mohammed, Emily Nhan

J Manag Care Spec Pharm· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19.
Melanie D Whittington, Steven D Pearson, David M Rind, Jonathan D Campbell

Value Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.
Melanie D Whittington, Jonathan D Campbell, David Rind, Noemi Fluetsch, Grace A Lin

Neurology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of Aducanumab.
Jonathan D Campbell, Melanie D Whittington, Steven D Pearson

Neurology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use.
Taryn A G Quinlan, Andrew W Roberts, Joseph W Frank, Melanie D Whittington

Health Serv Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and value of aducanumab for Alzheimer's disease.
Patricia G Synnott, Melanie D Whittington, Grace A Lin, David M Rind, Steven D Pearson

J Manag Care Spec Pharm· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systems-Based Morbidity and Mortality Conference Was Associated With a Transient Reduction in ECG Completion Times.
Andrew E Levy, Melanie D Whittington, Tyler J Anstett, Steven T Simon, Allen Wentworth

Qual Manag Health Care· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of a Sprint optimization and training intervention on time spent in the electronic health record (EHR).
Amber Sieja, Melanie D Whittington, Vanessa Paul Patterson, Katie Markley, Heather Holmstrom

JAMIA Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Payer Preferences for Additional Value Criteria.
Ivett Jakab, Melanie D Whittington, Elizabeth Franklin, Susan Raiola, Jonathan D Campbell

Front Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis